Healthcare & Medical

Wharton Biotech Conference 2026

T

he Wharton Biotech Conference 2026, presented by Penn Biotech Group, brings together industry leaders, professionals, and students to connect the Philadelphia biotech ecosystem. The event covers a broad range of topics including translational science, business and capital, AI's impact on drug development, commercialization, policy, workforce, and investment…

Visit the official site
7Voices
7Underwriters
0Exhibitors
1On the bill · sessions
13Companies · in total
§I

The Voices

Programmed at Wharton, in alphabetical order.
Ben Doranz
President & CEO · Integral Molecular
Christopher Pettigrew
Senior Director, Business Development (Global Corporate Development), GSK · GSK
David Baker
Head of Corporate Development, Nospharma; Board Director at GRI Bio and Devonian Health Group; Member of Robinhood Ventures · Nospharma / GRI Bio / Devonian Health Group / Robinhood Ventures
Pan Pan
Senior Vice President, Business Development, OncoC4 · OncoC4
Shivani Kadiyala
PBG Co-VP of Case Competition · Penn Biotech Group
Tiffany Wilson
President & CEO · Science Center
Tran Nguyen
Global Head Business Development & Licensing Finance at Novartis · Novartis
§II

Underwritten By

The houses behind the program. Tiers as disclosed.
Basis Health
BioBuzz
GSEG
Penn Law
Penn SP2
Science Center
Venture Lab
§III

The Programme

Selected from 1 sessions on the bill.
  • 2:30 PM

    Business & Capital: The Art of Business Development. From Collaboration to Acquisition.

Intermission
Part the Second · For the Buyer

What does it mean when 13 companies show up — and 1 bet on three roles at once?

“Thirteen companies. one are betting more than once.”

The numbers below are derived from the speakers, sponsors, and exhibitors on this page — cross-referenced into one ledger. They are the only thing here that 10times.com cannot tell you.

№ 01Fig. 01 — Composition of the House
1All threespeak · spons · exh
6Sponsoringsponsor only
0Exhibitingexhibitor only
6Companies Speakingspeaker only

The Triple-Threat

Science Center

№ 02Fig. 02 — The Voices, by Seniority

86% of the speakers carry senior titles — C-suite, Founder, VP, or Director-level.

  • C-suite229%
  • VP-level229%
  • Director / Head of229%
  • Other roles114%

Of 7 on the bill · classified by free-text title

№ 03Fig. 03 — The Heaviest in the Room
  1. 01Science CenterSp1V
  2. 02Basis HealthSp
  3. 03BioBuzzSp
  4. 04GSEGSp
  5. 05Penn LawSp
  6. 06Penn SP2Sp
  7. 07Venture LabSp
  8. 08GSK1V
  9. 09Integral Molecular1V
  10. 10Nospharma / GRI Bio / Devonian Health Group / Robinhood Ventures1V
  11. 11Novartis1V
  12. 12OncoC41V
  13. 13Penn Biotech Group1V
№ 04Fig. 04 — By Tier
unspecified7
100% of 7